Admittedly, I haven't read up enough on things, bu
Post# of 148177
I would also be shocked if, in the mild/moderate symptoms trial, there is not a protocol requirement/option to receive the drug if placebo patient progresses to the point (i.e., SEVERE) that they would need the drug.
I expect the mild/moderate symptoms trial exists, in part, to help rule out the placebo effect on immune markers without jeopardizing people's LIVES (like you would in the SEVERE trial if placebo was used).
Will be interesting to see what the endpoints of the trials are ...
Just my two cents.